Table 2 Comparisons between experimental and DDBP prediction results*
A | Â | B | C | D | E | F | G | H | I | J | K |
|---|---|---|---|---|---|---|---|---|---|---|---|
I | 11058-C7 | 249 | no | no | 4–190; 1–220; 80–190 | no | 24%, (7–240/8–268, 288); 26%, (4–240/7–225, 251) | (1–249)# | 1–249 | NP_506406 | F20G2.1 |
I | 11048-D3 | 199 | no | no | 9–199 | 76–98, 181–181 | 26%, (5–160/3–164, 208) | (1–199)$ | 1–199 | NP_502315 | F35G2.2 |
I | 11011-D8 | 190 | no | no | 8–36, 47–75, 83–111; 2–107; | 148–172, 108–120, 82–92, 49–51 | 27%, (37–105/1–69, 146) | (45–190)& | 1–107, 52–190 | NP_493641 | F23F1.2 |
I | 18-A2 | 210 | no | no | 29–79; 108–194 | no | 30%, (75–193/4–115, 135) | (74–210)& | 75–210 | NP_491893 | BAG1 (human) homolog family member (bag-1) |
I | 11033-F3 | 208 | no | no | 6–74; 128–194; 1–97; 80–207 | 39–56 | 31%, (2–207/1–197, 198) | (1–208)# | 1–208 | NP_496863 | Glutathione S-Transferase family member (gst-16) |
I | 11-D11 | 346 | no | no | 80–317; 55–320; 219–317 | 19–34, 116–126 | 31%, (76–334/36–291, 298) | (56–346)& | 55–346 | NP_491872 | C55B7.3 |
I | 11104-F4 | 370 | no | no | 2–221, 1–370 | 126–143, 348–352, 19–25, 71–82, 292–297, 233–237 | 34%, (128–347/15–231, 265) | (125–370, 1–124)& | 1–125, 128–347 | NP_001040820 | Cell Division Cycle related family member (cdc-37) |
I | 79-D4 | 401 | no | no | 65–395; 37–400 | 66–108, 27–45, 108–125, 217–236, 138–146 | 35%, (212–395/2– 185, 185) | (206–401)# | 212–401 | NP_491735 | C06A5.7b |
I | 9-H3 | 212 | no | no | no | 19–52, 162–192, 79–89 | 35%, (86–136/84– 131, 217) | (59–212)$ | 53–212 | NP_493365 | Y40B1B.5 |
I | 76-D4 | 254 | no | no | 2–171; 3–250; 139–167 | 139–147 | 36%, (3–251/8–265, 278) | (1–254)# | 1–254 | NP_001021765 | Y47G6A.22 |
I | 8-C1 | 142 | no | no | 4–140 | no | 46%, (5–141/9–149, 150) | (1–142)& | 1–142 | NP_499813 | T12D8.6 |
I | 11-F6 | 327 | no | 209– 231, 246– 268 | 207–227, 246–266 | 56–95, 19–56, 95–136, 136–161 | 50%, (141–167/1– 28, 163) | (1–182, 1–145)& | 1–135 | NP_491774 | T09B4.5a |
I | 1-F11 | 229 | no | no | 148–217; 170–201; 170–212 | 19–21, 129–134 | 59%, (135–220/20–107, 113) | (135–229)# | 135–229 | NP_506367 | F53F4.3 |
I | 3-H6 | 431 | no | no | 24–118, 141–234; 254–370; 261–370 | 397–413, 214–225, 100–107, 123–128 | 60%, (4–131/20–147, 149); 48%, (4–244/41–280, 280); 40%, (7–408/24–422, 457); 35%, (128–428/22–330, 336); | (1–135)# | 1–131, 128–244, 245–431 | NP_508026 | FK506-Binding protein family member (fkb-6) |
I | 20-H6 | 496 | no | no | 38–496; 186–261, 293–363, 422–483; 183–272, 275–374, 422–487 | 120–151, 265–279 | 66%, (394–496/1– 103, 104) ; 75%, (183–269/1– 87, 90); 75%, (290–366/1– 78, 85) | (169–385, 386–496)& | 183–272, 290–366, 394–496 | NP_001022967 | U2AF splicing factor family member (uaf-1) |
I | 1-D10 | 206 | 1–21 | no | 41–198; 23–77, 85–141, 143–196 | no | no | (23–206)# | 22–206 | NP_491320 | R12E2.13 |
I | 11020-H6** | 494 | no | no | 53–225; 337–475; 336–453; 236–494 | 19–52, 106–145, 215–241, 373–383, 325–330 | no | (1–237, 238–494) &$ | 53–225, 236–494, 331–494 | NP_493412 | Y37H9A.3 |
I | 70-H8 | 130 | no | 107– 129 | 109–129 | 19–104 | no | (1–130)# | 1–130 | NP_491052 | W03D8.3 |
I | 8-C9 | 183 | no | no | 125–159; | no | no | (1–183)# ; (28–183, 23–183)$ | 1–183 | NP_510277 | BMP receptor Associated protein family member (bra-1) |
I | 11005-B8 | 245 | no | no | no | 19–20, 129–136, 41–46 | no | (9–245)# | 1–245 | NP_740981 | R05F9.1b |
II | 18-F7 | 288 | no | no | 34–286 | 19–30, 72–78, 196–202, 66–70 | 45%, (35–286/21– 274, 276) | (32–266)$ | 34–286 | NP_001021584 | EXOnuclease family member (exo-3) |
II | 4-F5 | 592 | no | no | 189–269 | 485–509, 125–142, 19–37, 369–382,99–109, 311–317 | 35%, (210–269/15–74, 76); | (1–144)& | 1–124, 143–269 | NP_494544 | C16C8.16 |
II | 11011-C6 | 162 | no | no | 4–162; 5–54, 71–132 | 51–68 | no | (1–148, 1–124)& | 1–162 | NP_500324 | F42A6.6 |
II | 11058-H2 | 249 | no | no | 4–190; 4–230; 4–209 | no | 40%, (5–245/23– 263, 267) | (1–222)$ | 1–249 | NP_506407 | F20G2.2 |
II | 76-F10 | 263 | no | no | 23–130; 33–109 | 118–126, 20–20 | 27%, (27–120/6–98, 108) | (1–129)& | 21–130 | T26031 | hypothetical protein W01A8.2 |
II | 79-H11 | 245 | no | no | 2–156, 1–241 | 144–181, 181–204, 121–144 | 51%, (2–154/2–154, 155) | (1–185)$ | 1–156 | NP_492567 | C03D6.5 |
II | 25–B11 | 302 | no | no | 23–127; 45–114 | 203–236, 19–24, 236–248, 146–161, 187–195 | no | (1–153)& | 23–145 | NP_492781 | B0511.7 |
II | 11-D3 | 313 | no | no | 28–214; 9–302 | 151–174, 19–22 | no | (1–313)# ; (213–313)$ | 23–313 | NP_001021333 | Suppressor of PResenilin defect family member (spr-2) |
II | 11058-F12 | 272 | no | no | 40–63; 40–68, 90–124 | no | 32%, (67–119/3–54, 60); 26%, (40–119/5–84, 87); 31%, (41–114/36– 113, 124) | (1–147)& | 1–124 | NP_503566 | F36F12.8 |
III | 20-D7 | 500 | no | no | 311–395; 41–278; 283–436 | 387–417, 288–308, 453–469, 481–482 | 28%, (342–432/68–153, 289) | (1–500)# ; (298–500, 388–500, 407–500)$ | 1–287, 283–452 | NP_491868 | lariat DeBRanching enzyme related family member (dbr-1) |
III | 37-G9 | 245 | no | no | no | 206–227, 19–21 | no | (1–102, 103–245)& | 1–245 | NP_507040 | F14H3.6 |
III | 70-D2 | 265 | 1–25 | 15–37 | 69–243 | 223–247, 195–199 | 22%, (128–264/13–121, 135) | (1–130, 1–174)& | 1–265 | AAC25860 | Hypothetical protein C37C3.3 |
III | 2-B6 | 316 | no | no | 27–294 | 225–260, 174–191, 149–163, 296–298, 71–82, 84–84, 219–220 | 23%, (53–168/46– 180, 201) | (71–294)# ; (104–316)$& | 1–295 | NP_501422 | D2096.8 |
III | 10-E5 | 274 | no | no | 1–80, 108–190 | 229–246, 193–213 | 25%, (17–161/32– 166, 196) | (65–237, 1–74, 75–274)& | 1–192 | NP_502380 | C25G4.6 |
III | 3-D2 | 419 | no | no | 95–128, 133–166; 93–197; 133–166 | 196–217, 41–62, 259–275, 341–351, 19–21 | 26%, (95–239/13– 144, 166); 32%, (99–197/8–95, 118) | (140–309, 290–419)& | 93–197, 93–258 | NP_495087 | C17G10.2 |
III | 113-H8 | 588 | no | no | 232–342; 241–334 | 492–515, 19–56, 81–132, 150–185 | 29%, (234–328/2– 85, 105) | (1–345, 34–313)& | 232–342 | NP_740981 | R05F9.1b |
III | 76-F6 | 803 | no | 769– 791 | 17–250, 558–652; 10–34, 111–148, 382–402 | 752–767, 19–24, 717–727, 280–281 | 29%, (62–257/5– 200, 205); 29%, (83–257/1– 175, 181) | (1–181)& | 25–257 | NP_491008 | alpha-CaTuliN (catenin/vinculin related) family member (ctn-1) |
III | 4-A4 | 569 | no | no | 164–338, 369–527;187–200, 206–222, 263–279, 305–321, 321–335, 506–527; 263–318, 388–452, 511–568 | 65–97, 19–38,112–139 | 32%, (154–567/18–397, 402) | (334–542, 334–501)&; (1–569)# | 154–549 | NP_495753 | associated with RAN (nuclear import/export) function family member (ran-3) |
III | 25-H8 | 339 | no | no | 24–84; 24–75 | 215–276, 111–169, 187–201, 100–109 | 41%, (22–75/7–61, 70) | (1–152)& | 1–99 | NP_495652 | T09A5.8 |
III | 2-H9 | 356 | no | no | 22–273; 1–108, 115–297; 13–284 | 192–215, 303–312, 338 | 42%, (1–284/1–289, 382) | (1–335, 1–356) $& | 1–197 | NP_497949 | T23F11.1 |
III | 18-H1 | 208 | no | no | 32–124; 36–113; 24–45, 51–68, 131–145, 164–181, 186–205 | 171–190, 114–171, 19–40 | 43%, (41–110/10– 76, 90) | (1–81)&$ | 32–124 | NP_510410 | HIStone family member (his-24) |
III | 11049-D6 | 435 | no | no | 293–433; 270–433 | 110–152, 234–260, 175–186, 375–381 | no | (1–156)# ; (9–158, 1–119)$& | 261–435 | NP_001041025 | Y41E3.7a |
III | 9-G11 | 250 | no | no | 1–194 | 228–232 | no | (35–250)& | 1–227 | NP_497076 | R05H10.1 |
III | 10-E1 | 251 | no | no | no | 158–199 | no | (1–206)& | 1–251 | NP_496943 | W01G7.4 |
III | 37-F11 | 230 | no | no | 1–230 | 106–126, 168–182 | no | (45–179, 45–230)& | 1–230 | NP_507024 | T10C6.5 |
III | 75-A8 | 228 | no | no | no | 19–44, 125–135 | no | (1–189)$& | 1–228 | NP_492509 | F46A9.1 |
III | 11048-E2 | 262 | no | no | 33–178; 61–179 | 183–198 | no | (1–262)$ | 1–182 | NP_501337 | MEChanosensory abnormality family member (mec-17) |